Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michele Carbone

Showing results (141-150 of 167) with videos related to

Pageof 17
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 5, 2025
A Response to the Letter to the Editor: Refining Risk and Redefining Stage: Hidden Implications of BAP1-Mutant Mesothelioma Shiuan-Chih Chen, MD, PhD; Yuan-Ti Lee, MD, PhDMichele Carbone, Michael Minaai, Muaiad Kittaneh, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 12, 2016
High-density array-CGH with targeted NGS unmask multiple noncontiguous minute deletions on chromosome 3p21 in mesotheliomaYoshie Yoshikawa, Mitsuru Emi, Tomoko Hashimoto-Tamaoki, et al.
Nature Genetics|August 30, 2011
Germline BAP1 mutations predispose to malignant mesotheliomaJoseph R Testa, Mitchell Cheung, Jianming Pei, et al.
Cancer Research|January 29, 2020
The Tumor Suppressor BAP1 Regulates the Hippo Pathway in Pancreatic Ductal AdenocarcinomaHo-June Lee, Trang Pham, Matthew T Chang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 29, 2025
Clinical and Pathologic Phenotyping of mesotheliomas developing in carriers of Germline BAP1 MutationsMichele Carbone, Michael Minaai, Muaiad Kittaneh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 31, 2018
A Subset of Mesotheliomas With Improved Survival Occurring in Carriers of BAP1 and Other Germline MutationsSandra Pastorino, Yoshie Yoshikawa, Harvey I Pass, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 14, 2010
Cancer and inflammation: promise for biologic therapySandra Demaria, Eli Pikarsky, Michael Karin, et al.
Journal of Toxicology and Environmental Health. Part B, Critical Reviews|October 6, 2016
Investigating palygorskite's role in the development of mesothelioma in southern Nevada: Insights into fiber-induced carcinogenicityDavid Larson, Amy Powers, Jean-Paul Ambrosi, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 24, 2021
BAP1 forms a trimer with HMGB1 and HDAC1 that modulates gene × environment interaction with asbestosFlavia Novelli, Angela Bononi, Qian Wang, et al.
Plos Genetics|December 20, 2015
Combined Genetic and Genealogic Studies Uncover a Large BAP1 Cancer Syndrome Kindred Tracing Back Nine Generations to a Common Ancestor from the 1700sMichele Carbone, Erin G Flores, Mitsuru Emi, et al.
Pageof 17

Showing results (141-150 of 167) with videos related to

Sort By:
Pageof 17
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 5, 2025
A Response to the Letter to the Editor: Refining Risk and Redefining Stage: Hidden Implications of BAP1-Mutant Mesothelioma Shiuan-Chih Chen, MD, PhD; Yuan-Ti Lee, MD, PhDMichele Carbone, Michael Minaai, Muaiad Kittaneh, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 12, 2016
High-density array-CGH with targeted NGS unmask multiple noncontiguous minute deletions on chromosome 3p21 in mesotheliomaYoshie Yoshikawa, Mitsuru Emi, Tomoko Hashimoto-Tamaoki, et al.
Nature Genetics|August 30, 2011
Germline BAP1 mutations predispose to malignant mesotheliomaJoseph R Testa, Mitchell Cheung, Jianming Pei, et al.
Cancer Research|January 29, 2020
The Tumor Suppressor BAP1 Regulates the Hippo Pathway in Pancreatic Ductal AdenocarcinomaHo-June Lee, Trang Pham, Matthew T Chang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 29, 2025
Clinical and Pathologic Phenotyping of mesotheliomas developing in carriers of Germline BAP1 MutationsMichele Carbone, Michael Minaai, Muaiad Kittaneh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 31, 2018
A Subset of Mesotheliomas With Improved Survival Occurring in Carriers of BAP1 and Other Germline MutationsSandra Pastorino, Yoshie Yoshikawa, Harvey I Pass, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 14, 2010
Cancer and inflammation: promise for biologic therapySandra Demaria, Eli Pikarsky, Michael Karin, et al.
Journal of Toxicology and Environmental Health. Part B, Critical Reviews|October 6, 2016
Investigating palygorskite's role in the development of mesothelioma in southern Nevada: Insights into fiber-induced carcinogenicityDavid Larson, Amy Powers, Jean-Paul Ambrosi, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 24, 2021
BAP1 forms a trimer with HMGB1 and HDAC1 that modulates gene × environment interaction with asbestosFlavia Novelli, Angela Bononi, Qian Wang, et al.
Plos Genetics|December 20, 2015
Combined Genetic and Genealogic Studies Uncover a Large BAP1 Cancer Syndrome Kindred Tracing Back Nine Generations to a Common Ancestor from the 1700sMichele Carbone, Erin G Flores, Mitsuru Emi, et al.
Pageof 17